China At ASCO: Biotech Pharma, Akeso, Chongqing Precision Showcase Promising Data

Oncology Rise Continues

 
• By Dexter Jie Yan

EGFR-targeting antibody, anti-PD-1/CTLA4 bispecific antibody and CD19-targeting CAR-T therapy from emerging Chinese oncology companies shine at one of ASCO’s most-watched sessions.

symposium
Notable data readouts from three Chinese biotechs catch attention at ASCO • Source: Shutterstock

More from China

More from Focus On Asia